Advertisement
U.S. Markets closed

Protagonist Therapeutics, Inc. (PTGX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Visitors trend2W10W9M
46.23-1.38 (-2.90%)
At close: 04:00PM EST
46.23 0.00 (0.00%)
After hours: 04:02PM EST
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
35,198
60,000
26,581
27,357
28,628
Operating Expense
167,071
153,652
157,954
153,202
93,144
Operating Income
-131,873
-93,652
-131,373
-125,845
-64,516
Net Non Operating Interest Income Expense
1,931
14,898
4,060
443
302
Other Income Expense
-164
-201
-80
-149
-631
Pretax Income
-130,106
-78,955
-127,393
-125,551
-64,845
Tax Provision
-
-
0
0
1,305
Net Income Common Stockholders
-130,106
-78,955
-127,393
-125,551
-66,150
Diluted NI Available to Com Stockholders
-130,106
-78,955
-127,393
-125,551
-66,150
Basic EPS
-2.71
-1.39
-2.60
-2.71
-1.92
Diluted EPS
-2.71
-1.39
-2.60
-2.71
-1.92
Basic Average Shares
46,323
56,764
49,042
46,323
34,396
Diluted Average Shares
46,323
56,764
49,042
46,323
34,396
Total Operating Income as Reported
-131,873
-93,652
-131,373
-125,845
-64,516
Total Expenses
167,071
153,652
157,954
153,202
93,144
Net Income from Continuing & Discontinued Operation
-130,106
-78,955
-127,393
-125,551
-66,150
Normalized Income
-130,106
-78,955
-127,393
-125,551
-65,723
Interest Income
1,931
14,898
4,060
443
900
Interest Expense
-
-
0
0
598
Net Interest Income
1,931
14,898
4,060
443
302
EBIT
-131,579
-93,652
-131,373
-125,845
-64,247
EBITDA
-128,231
-90,340
-128,004
-123,070
-61,524
Reconciled Depreciation
3,348
3,312
3,369
2,775
2,723
Net Income from Continuing Operation Net Minority Interest
-130,106
-78,955
-127,393
-125,551
-66,150
Total Unusual Items Excluding Goodwill
0
-
0
0
-585
Total Unusual Items
0
-
0
0
-585
Normalized EBITDA
-128,231
-90,340
-128,004
-123,070
-60,939
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
-157.95